Our clients rely on our services to inform their activities and decision-making for products in all stages of development and those on the market. Pinney Associates experts help our clients to understand and establish the science and public health basis for commercial, public policy and regulatory actions. These case studies show how this expertise benefits our clients.
A medium-sized pharmaceutical company had received a non-approvable letter for a new formulation of a stimulant drug. One major deficiency was an inadequate Risk Management Program.
A medium-sized pharmaceutical company was conducting due diligence on a stimulant in early stages of development which is an analog of a currently marketed product.
A large pharmaceutical company contracted Pinney Associates to support the prescription to over-the-counter switch of an established product in a new OTC category.
